News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Renewed U.S.-Iran hostilities lifted oil prices and inflation-sensitive Treasury yields.
  • U.S. mortgage rates rose to near year-highs, pushing the 30-year fixed rate higher.
  • Mortgage application volumes fell last week, with refinances showing the largest decline.
  • The Lancet published Phase 3 HOPE-3 data showing Deramiocel slowed Duchenne muscular dystrophy progression by 54%.
  • Capricor's Biologics License Application for Deramiocel is under active FDA review with a PDUFA date of Aug 22, 2026.
  • SCWorx received a Nasdaq hearings panel partial compliance letter after meeting the minimum bid-price requirement for 20 consecutive days.
  • Hyperion DeFi scheduled its second-quarter earnings call for Aug 12, 2026 at 5:00 p.m. ET.

Latest Articles

Solana Company Reports First Quarter 2026 Financial Results

Solana Company Reports First Quarter 2026 Financial Results

Solana Company (NASDAQ: HSDT) reported Q1 2026 revenue of $3.6 million primarily from staking rewards, a substantial increase from the previous year. Despite strong gross profits, the company reported a net loss of $99.8 million due to large non-cash unrealized digital asset losses and operational expenses. The company continued capital allocation …

Binah Capital Group Reports Results for First Quarter of 2026

Binah Capital Group Reports Results for First Quarter of 2026

Binah Capital Group, Inc. announced its first quarter 2026 results marked by a 12.9% increase in assets under management to $29.0 billion, a near doubling of net income to $1.9 million, and a 50% increase in EBITDA compared to the prior year period. Despite stable total revenues around $48.7 million, the company achieved higher profitability and st…

Covenant Logistics Group Announces Quarterly Cash Dividend

Covenant Logistics Group Announces Quarterly Cash Dividend

Covenant Logistics Group, Inc. announced a quarterly cash dividend of $0.07 per share for both Class A and Class B common stock, payable on June 26, 2026, to shareholders of record as of June 5, 2026. The dividend distribution aligns with the company's approved cash dividend program, though future dividends remain subject to board approval and fina…

Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ™ Clinical Program and CNSide® Commercial Rollout

Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ™ Clinical Program and CNSide® Commercial Rollout

Plus Therapeutics announced its first quarter 2026 financial results highlighting progress in its CNSide commercial expansion and REYOBIQ clinical development programs. The company secured FDA Orphan Drug Designation for REYOBIQ in pediatric malignant gliomas, expanded payer coverage for CNSide to approximately 81 million covered lives, and complet…

Candel Therapeutics Reports Extended Clinical Benefit Over Multiple Clinical Endpoints in Patients from Phase 3 Trial of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer Under Prolonged Follow-up at AUA 2026 Annual Meeting

Candel Therapeutics Reports Extended Clinical Benefit Over Multiple Clinical Endpoints in Patients from Phase 3 Trial of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer Under Prolonged Follow-up at AUA 2026 Annual Meeting

Candel Therapeutics reported extended phase 3 clinical trial results for its lead immunotherapy candidate, aglatimagene besadenovec (CAN-2409), in intermediate- to high-risk localized prostate cancer. After a median of 58 months follow-up, the therapy demonstrated a statistically significant 39% improvement in prostate cancer-specific disease-free …

Rani Therapeutics Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition

Rani Therapeutics Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition

Rani Therapeutics released its Q1 2026 financial results, highlighting progress in its Phase 1 clinical study of RT-114, an oral obesity treatment using its RaniPill® technology in collaboration with ProGen. The company appointed key strategic executives and announced a CFO transition while maintaining adequate cash to fund operations into late 202…

Deepwater’s Munster Sees Upside for Nvidia from H200 China Clearance

Deepwater’s Munster Sees Upside for Nvidia from H200 China Clearance

U.S. approval for Nvidia to supply H200 GPUs to roughly 10 Chinese companies, including Alibaba, Tencent, and ByteDance, opens the door to incremental revenue in calendar year 2027, according to Gene Munster of Deepwater Asset Management. While the clearance could produce mid-single-digit upside to CY27 revenue under base assumptions and higher in …

Insider Activity and Analyst Sentiment Cloud PAYX Stock Amid Recent Sales

Insider Activity and Analyst Sentiment Cloud PAYX Stock Amid Recent Sales

A recent SEC filing disclosed that Elizabeth Roaldsen, Senior Vice President at Paychex Inc., sold a block of company common stock. This transaction occurred as the shares were trading near their 52-week low. Despite this insider selling activity and general market price weakness, recent financial reports showed strong revenue growth and earnings p…

U.S. Move to Indict Raul Castro Intensifies Strains in Cuba Amid Fuel Shortages

U.S. Move to Indict Raul Castro Intensifies Strains in Cuba Amid Fuel Shortages

Plans by U.S. authorities to pursue criminal charges against former Cuban leader Raul Castro in connection with the 1996 downing of humanitarian aircraft have amplified tensions on the island. The potential indictment arrives at a moment of acute domestic strain, with severe fuel shortages and rising public unease. Cuban officials have issued defia…

Matson SVP's Stock Sale Occurs Amid Mixed Q1 Earnings Report

Matson SVP's Stock Sale Occurs Amid Mixed Q1 Earnings Report

Senior Vice President Jason Lee Taylor sold a block of company shares in May 2026. This transaction occurred against the backdrop of Matson's recent first-quarter 2026 earnings release, which displayed mixed financial signals: EPS exceeded expectations but revenue fell short of analyst forecasts. Investors are closely monitoring these conflicting r…

Exxon Mobil Faults ISS Over Recommendation Against Texas Redomicile

Exxon Mobil Faults ISS Over Recommendation Against Texas Redomicile

Exxon Mobil has publicly rebuked Institutional Shareholder Services for advising investors to oppose the company's proposal to move its legal domicile to Texas. Exxon charged ISS with using a faulty analysis and failing to disclose a conflict tied to ongoing litigation with the Texas Attorney General, and pushed back against ISS commentary on poten…

Hydrofarm Holdings Group Announces First Quarter 2026 Results

Hydrofarm Holdings Group Announces First Quarter 2026 Results

Hydrofarm Holdings Group, Inc. announced first quarter 2026 financial results with net sales down 29.6% year-over-year to $28.5 million, gross profit margin dropping to 6.4%, and a net loss of $14.6 million. The company is experiencing lower volume due to industry oversupply and has taken significant cost reduction measures including consolidating …

PDF Solutions® Announces Full Exercise of Greenshoe Option and Closing of Upsized Public Offering of Common Stock

PDF Solutions® Announces Full Exercise of Greenshoe Option and Closing of Upsized Public Offering of Common Stock

PDF Solutions successfully closed an upsized underwritten public offering of 5.25 million shares at $44.00 per share, including the full exercise of the underwriters' greenshoe option. The company raised approximately $85.7 million in gross proceeds, strengthening its capital base to support ongoing growth in semiconductor data solutions.

Farhadi Laments Toll of Iran Crackdown and Ongoing War as Cannes Premiere Unfolds

Farhadi Laments Toll of Iran Crackdown and Ongoing War as Cannes Premiere Unfolds

At the Cannes Film Festival, two-time Oscar-winning Iranian director Asghar Farhadi said he remains profoundly affected by the deaths linked to a January crackdown on protesters and by the subsequent war that has involved Iran and the wider Middle East. Speaking after the premiere of his new film, Farhadi said the losses are unforgettable and that …

Microsoft Has Turned the Corner - How AI and Cloud Re-accelerate Growth

Microsoft Has Turned the Corner - How AI and Cloud Re-accelerate Growth

Microsoft is showing signs of a fundamental inflection: cloud monetization, Copilot AI integration, and a clean balance sheet are translating into accelerating earnings and cash flow. At $421.98 the stock offers a favorable asymmetric trade vs. the 52-week high of $555.45 and the 52-week low of $356.28. This trade plan uses a tested entry, tight st…

CDC Tracks Ebola Cases in DRC and Uganda, Offers Technical Support

CDC Tracks Ebola Cases in DRC and Uganda, Offers Technical Support

The U.S. Centers for Disease Control and Prevention is actively monitoring Ebola outbreaks in the Democratic Republic of Congo and Uganda and is providing technical assistance to both governments, the agency's acting director said. CDC officials are working through existing country offices to coordinate with local health authorities as they track a…